基本信息
浏览量:259
职业迁徙
个人简介
Dr. Kantarjian has received several prestigious honors and awards including the 37th Jeffrey A Gottlieb Memorial Award (2012), the John Mendelsohn Lifetime Scientific Achievement Award (2008), the Joseph H. Burchenal Memorial Award (2013),the Charles A. LeMaistre, M.D. Outstanding Achievement Award in Cancer (2014), and America’s Top Doctors, Castle Connolly Medical (2003-present). He was also selected the top Castle Connolly National Physician of the Year Award for Lifetime Achievement (2014) and the ASCO David A. Karnofsky Memorial Award for lifelong contributions to leukemia research and patient care (2023).
Dr. Kantarjian’s research focuses on translational-clinical developmental therapeutics in leukemia. In the past four decades, he has made several contributions that improved prognosis and survival in patients with chronic myeloid leukemia (tyrosine kinase inhibitors, e.g. imatinib, dasatinib, nilotinib, bosutinib which improved the 10-year survival from 20% to 90%), in acute lymphocytic leukemia (HPER-CVAD regimen and its derivatives which improved cure rates from 20% to 60+%), the discovery of decitabine for the treatment of myelodysplastic syndrome, and of clofarabine for the treatment of leukemias, among others. His research and collaborations were the basis for the FDA approvals of over 20 drugs in leukemia. He is an author on over 2,000 peer-reviewed publications.
Dr. Kantarjian’s research focuses on translational-clinical developmental therapeutics in leukemia. In the past four decades, he has made several contributions that improved prognosis and survival in patients with chronic myeloid leukemia (tyrosine kinase inhibitors, e.g. imatinib, dasatinib, nilotinib, bosutinib which improved the 10-year survival from 20% to 90%), in acute lymphocytic leukemia (HPER-CVAD regimen and its derivatives which improved cure rates from 20% to 60+%), the discovery of decitabine for the treatment of myelodysplastic syndrome, and of clofarabine for the treatment of leukemias, among others. His research and collaborations were the basis for the FDA approvals of over 20 drugs in leukemia. He is an author on over 2,000 peer-reviewed publications.
研究兴趣
论文共 5566 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yaqi Zhao,Nicholas J. Short,Hagop M. Kantarjian,Ti-Cheng Chang,Pankaj S. Ghate,Chunxu Qu,Walid Macaron,Nitin Jain,Beenu Thakral,Aaron H. Phillips,Joseph Khoury,Guillermo Garcia-Manero, Wenchao Zhang,Yiping Fan, Hui Yang,Rebecca S. Garris,Lewis F. Nasr,Richard W. Kriwacki,Kathryn G. Roberts,Marina Konopleva,Elias J. Jabbour,Charles G. Mullighan
Jayastu Senapati,Hagop M. Kantarjian,Alexandre Bazinet,Patrick Reville,Nicholas J. Short,Naval Daver,Gautam Borthakur,Alex Bataller,Elias Jabbour,Courtney Dinardo,Fadi Haddad,Koji Sasaki,Uday Popat,Betul Oran,Amin M. Alousi,Sanam Loghavi,Elizabeth Shpall,Guillermo Garcia-Manero,Farhad Ravandi,Tapan M. Kadia
Cancer (2024)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIAno. 5 (2024): 285-297
Journal of the National Comprehensive Cancer Network : JNCCNno. 1 (2024)
Clinical lymphoma, myeloma & leukemiano. 10 (2024): e376-e384
Elias Jabbour,Gerhard Zugmaier,Vaibhav Agrawal,Pilar Martinez-Sanchez,Jose J. Rifon Roca,Ryan D. Cassaday, Boris Boell,Anita Rijneveld,Maher Abdul-Hay,Francoise Huguet,Thomas Cluzeau,Mar Tormo Diaz,Vladan Vucinic,Jose Gonzalez-Campos,Alessandro Rambaldi,Stefan Schwartz,Celine Berthon,Jesus Maria Hernandez-Rivas,Paul R. Gordon,Monika Brueggemann,Ali Hamidi,Yuqi Chen,Hansen L. Wong, Bharat Panwar,Yuliya Katlinskaya,Ana Markovic,Hagop Kantarjian
American journal of hematologyno. 4 (2024): 586-595
Branko Cuglievan,Hagop Kantarjian, Jeffrey E Rubnitz,Todd M Cooper,C Michel Zwaan,Jessica A Pollard,Courtney D DiNardo,Tapan M Kadia,Erin Guest,Nicholas J Short,David McCall,Naval Daver,Cesar Nunez,Fadi G Haddad,Miriam Garcia,Kapil N Bhalla, Abhishek Maiti,Samanta Catueno,Warren Fiskus,Bing Z Carter,Amber Gibson,Michael Roth,Sajad Khazal,Priti Tewari,Hussein A Abbas,Wallace Bourgeois,Michael Andreeff,Neerav N Shukla,Danh D Truong, Jeremy Connors,Joseph A Ludwig,Janine Stutterheim,Elisabeth Salzer, Kristian L Juul-Dam,Koji Sasaki,Kris M Mahadeo,Sarah K Tasian,Gautam Borthakur, Samantha Dickson,Nitin Jain,Elias Jabbour,Soheil Meshinchi,Guillermo Garcia-Manero,Farhad Ravandi,Eytan M Stein,E Anders Kolb,Ghayas C Issa
Leukemia (2024)
Leukemiano. 5 (2024): 1-4
Blood Neoplasiapp.100008, (2024)
American journal of hematologyno. 4 (2024): 792-796
加载更多
作者统计
#Papers: 5639
#Citation: 276663
H-Index: 227
G-Index: 411
Sociability: 9
Diversity: 0
Activity: 26
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn